Open claims vs. closed payer claims: What’s the difference?
Open claims and closed payer claims data are essential for understanding the status and activities...
Open claims and closed payer claims data are essential for understanding the status and activities...
Understanding mortality in taXonomy and the importance of post mortem activity This is the third...
A better way to measure healthcare costs in closed claims data This is the second post in our...
Capturing the true complexity of psoriasis in the real world Psoriasis is a common chronic...
As the new year begins, many patients refocus on weight management and long-term health goals. At...
Industry trends in ulcerative colitis research: a new path Ulcerative colitis is a chronic...
Alzheimer’s disease burden and the current therapy pipeline Alzheimer’s disease remains the leading...
Identifying the gaps in today’s real-world data The 2025 IMPACCT Real-World Evidence Summit brought...
October is Breast Cancer Awareness Month. While pink ribbons and fundraising campaigns help bring...
In a recent webinar, the HealthVerity team including Alexa Woodward, Ph.D., Director of Strategic...
Most life sciences teams don't have a data shortage. They have blind spots such as patients who drop out of view, therapies that never appear in the claims they license, and clinical context that never makes it into a structured field. In a recent we...